Pre-stroke glycemia in patients with diabetes

Amrinder Singh, Desiree D. Brooks, Taryn A. Abrams, Mitra D. Poorak, Drew Gunio, Prianka K. Kandhal, Aleena Lakhanpal, Sankara N Sethuraman, Askiel Bruno

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Aims Hyperglycemia in type 2 diabetes mellitus (T2D) remains uncontrolled in approximately 50% of patients in the United States. Uncontrolled T2D is associated with various vascular complications, including stroke. We studied demographic and clinical factors association with pre-stroke glycemia, indicated by glycated hemoglobin (HbA1c), in acute stroke patients with T2D. Methods Using a questionnaire, we collected demographic, socioeconomic, and clinical information from 300 acute ischemic and hemorrhagic stroke patients in one hospital. We analyzed factors associated with HbA1c in patients with history of T2D. Results There were 111 patients with history of T2D and HbA1c measured on admission. In multivariable analyses factors associated with higher HbA1c were treatment with insulin (p = 0.05), history of hyperlipidemia (p = 0.01), and total cholesterol level (p = 0.02). Poor adherence to T2D treatment was associated with higher HbA1c levels (p = 0.006) only in a subgroup of patients with HbA1c ≥8%. Conclusion Insulin treatment and hyperlipidemia are associated with higher HbA1c levels in acute stroke patients with T2D. Poor adherence to diabetes treatment is associated with higher HbA1c levels only among patients with HbA1c ≥8%.

Original languageEnglish (US)
Pages (from-to)S891-S893
JournalDiabetes and Metabolic Syndrome: Clinical Research and Reviews
Volume11
DOIs
StatePublished - Dec 1 2017

Fingerprint

Type 2 Diabetes Mellitus
Stroke
Hyperlipidemias
Demography
Insulin
Glycosylated Hemoglobin A
Therapeutics
Hyperglycemia
Statistical Factor Analysis
Blood Vessels
Cholesterol

Keywords

  • Diabetes
  • Hyperglycemia
  • Stroke

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Singh, A., Brooks, D. D., Abrams, T. A., Poorak, M. D., Gunio, D., Kandhal, P. K., ... Bruno, A. (2017). Pre-stroke glycemia in patients with diabetes. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 11, S891-S893. https://doi.org/10.1016/j.dsx.2017.07.011

Pre-stroke glycemia in patients with diabetes. / Singh, Amrinder; Brooks, Desiree D.; Abrams, Taryn A.; Poorak, Mitra D.; Gunio, Drew; Kandhal, Prianka K.; Lakhanpal, Aleena; Sethuraman, Sankara N; Bruno, Askiel.

In: Diabetes and Metabolic Syndrome: Clinical Research and Reviews, Vol. 11, 01.12.2017, p. S891-S893.

Research output: Contribution to journalArticle

Singh, A, Brooks, DD, Abrams, TA, Poorak, MD, Gunio, D, Kandhal, PK, Lakhanpal, A, Sethuraman, SN & Bruno, A 2017, 'Pre-stroke glycemia in patients with diabetes', Diabetes and Metabolic Syndrome: Clinical Research and Reviews, vol. 11, pp. S891-S893. https://doi.org/10.1016/j.dsx.2017.07.011
Singh, Amrinder ; Brooks, Desiree D. ; Abrams, Taryn A. ; Poorak, Mitra D. ; Gunio, Drew ; Kandhal, Prianka K. ; Lakhanpal, Aleena ; Sethuraman, Sankara N ; Bruno, Askiel. / Pre-stroke glycemia in patients with diabetes. In: Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2017 ; Vol. 11. pp. S891-S893.
@article{c02e0f43746e4daaab9cc8ac6857a67f,
title = "Pre-stroke glycemia in patients with diabetes",
abstract = "Aims Hyperglycemia in type 2 diabetes mellitus (T2D) remains uncontrolled in approximately 50{\%} of patients in the United States. Uncontrolled T2D is associated with various vascular complications, including stroke. We studied demographic and clinical factors association with pre-stroke glycemia, indicated by glycated hemoglobin (HbA1c), in acute stroke patients with T2D. Methods Using a questionnaire, we collected demographic, socioeconomic, and clinical information from 300 acute ischemic and hemorrhagic stroke patients in one hospital. We analyzed factors associated with HbA1c in patients with history of T2D. Results There were 111 patients with history of T2D and HbA1c measured on admission. In multivariable analyses factors associated with higher HbA1c were treatment with insulin (p = 0.05), history of hyperlipidemia (p = 0.01), and total cholesterol level (p = 0.02). Poor adherence to T2D treatment was associated with higher HbA1c levels (p = 0.006) only in a subgroup of patients with HbA1c ≥8{\%}. Conclusion Insulin treatment and hyperlipidemia are associated with higher HbA1c levels in acute stroke patients with T2D. Poor adherence to diabetes treatment is associated with higher HbA1c levels only among patients with HbA1c ≥8{\%}.",
keywords = "Diabetes, Hyperglycemia, Stroke",
author = "Amrinder Singh and Brooks, {Desiree D.} and Abrams, {Taryn A.} and Poorak, {Mitra D.} and Drew Gunio and Kandhal, {Prianka K.} and Aleena Lakhanpal and Sethuraman, {Sankara N} and Askiel Bruno",
year = "2017",
month = "12",
day = "1",
doi = "10.1016/j.dsx.2017.07.011",
language = "English (US)",
volume = "11",
pages = "S891--S893",
journal = "Diabetes and Metabolic Syndrome: Clinical Research and Reviews",
issn = "1871-4021",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Pre-stroke glycemia in patients with diabetes

AU - Singh, Amrinder

AU - Brooks, Desiree D.

AU - Abrams, Taryn A.

AU - Poorak, Mitra D.

AU - Gunio, Drew

AU - Kandhal, Prianka K.

AU - Lakhanpal, Aleena

AU - Sethuraman, Sankara N

AU - Bruno, Askiel

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Aims Hyperglycemia in type 2 diabetes mellitus (T2D) remains uncontrolled in approximately 50% of patients in the United States. Uncontrolled T2D is associated with various vascular complications, including stroke. We studied demographic and clinical factors association with pre-stroke glycemia, indicated by glycated hemoglobin (HbA1c), in acute stroke patients with T2D. Methods Using a questionnaire, we collected demographic, socioeconomic, and clinical information from 300 acute ischemic and hemorrhagic stroke patients in one hospital. We analyzed factors associated with HbA1c in patients with history of T2D. Results There were 111 patients with history of T2D and HbA1c measured on admission. In multivariable analyses factors associated with higher HbA1c were treatment with insulin (p = 0.05), history of hyperlipidemia (p = 0.01), and total cholesterol level (p = 0.02). Poor adherence to T2D treatment was associated with higher HbA1c levels (p = 0.006) only in a subgroup of patients with HbA1c ≥8%. Conclusion Insulin treatment and hyperlipidemia are associated with higher HbA1c levels in acute stroke patients with T2D. Poor adherence to diabetes treatment is associated with higher HbA1c levels only among patients with HbA1c ≥8%.

AB - Aims Hyperglycemia in type 2 diabetes mellitus (T2D) remains uncontrolled in approximately 50% of patients in the United States. Uncontrolled T2D is associated with various vascular complications, including stroke. We studied demographic and clinical factors association with pre-stroke glycemia, indicated by glycated hemoglobin (HbA1c), in acute stroke patients with T2D. Methods Using a questionnaire, we collected demographic, socioeconomic, and clinical information from 300 acute ischemic and hemorrhagic stroke patients in one hospital. We analyzed factors associated with HbA1c in patients with history of T2D. Results There were 111 patients with history of T2D and HbA1c measured on admission. In multivariable analyses factors associated with higher HbA1c were treatment with insulin (p = 0.05), history of hyperlipidemia (p = 0.01), and total cholesterol level (p = 0.02). Poor adherence to T2D treatment was associated with higher HbA1c levels (p = 0.006) only in a subgroup of patients with HbA1c ≥8%. Conclusion Insulin treatment and hyperlipidemia are associated with higher HbA1c levels in acute stroke patients with T2D. Poor adherence to diabetes treatment is associated with higher HbA1c levels only among patients with HbA1c ≥8%.

KW - Diabetes

KW - Hyperglycemia

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=85022037114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85022037114&partnerID=8YFLogxK

U2 - 10.1016/j.dsx.2017.07.011

DO - 10.1016/j.dsx.2017.07.011

M3 - Article

C2 - 28705459

AN - SCOPUS:85022037114

VL - 11

SP - S891-S893

JO - Diabetes and Metabolic Syndrome: Clinical Research and Reviews

JF - Diabetes and Metabolic Syndrome: Clinical Research and Reviews

SN - 1871-4021

ER -